Avecho Biotechnology Revenue

In the year 2024, Avecho Biotechnology had annual revenue of 1.13M AUD with 139.19% growth. Avecho Biotechnology had revenue of 820.49K in the half year ending December 31, 2024, with 121.14% growth.

Revenue

1.13M AUD

Revenue Growth

+139.19%

P/S Ratio

11.83

Revenue / Employee

75.51K AUD

Employees

Market Cap

8.30M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.13M	659.12K	139.19%
Dec 31, 2023	473.55K	-655.71K	-58.07%
Dec 31, 2022	1.13M	335.66K	42.30%
Dec 31, 2021	793.60K	408.97K	106.33%
Dec 31, 2020	384.63K	-3.85M	-90.92%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo, Inc.	1.73B
Elite Pharmaceuticals	70.00M
Veradigm	588.02M
Tian'an Technology Group	1.78M
Glass House Brands	215.62M
Northwest Biotherapeutics	1.47M
American Oncology Network	1.76B
Silence Therapeutics	27.70M

Revenue Rankings